InsiderClue
Insiders · Profile

Monohon Ted

Chief Accounting Officer & VP at Quince Therapeutics. Filing since 6 Mar 2023. CIK 0001606905

Company
Date
Role
Action
Shares
Amount
Of holding
QNCX Quince Therapeutics, Inc.
6 Mar 2023
Chief Accounting Officer & VP
Sold, plan not stated
1,871
$1.83K
6.4%
1 decision on file.